BioMarin Pharmaceutical
Earnings Date & Report
Last updated:
BioMarin Pharmaceutical’s last earnings date was on 26 Feb 2024.
BioMarin Pharmaceutical stock Earnings report, Estimates & History
| 2019-08-01 | 0.1643 | 0.09 |
|---|---|---|
| 2019-10-23 | -0.92541 | 0.3 |
| 2020-02-26 | -0.10158 | 0.08 |
| 2020-04-29 | -2.84306 | 0.44 |
| 2020-08-04 | 0.522 | 0.32 |
| 2020-11-05 | -4.98964 | 4.01 |
| 2021-02-25 | -0.0754 | 0.12 |
| 2021-04-29 | -0.1209 | 0.09 |
| 2021-07-28 | -0.04414 | 0.07 |
| 2021-10-27 | 0.1452 | 0.18 |
| 2022-02-23 | 0.02991 | 0.03 |
| 2022-04-27 | -1.04756 | 0.63 |
| 2022-08-03 | 0.1009 | 0.15 |
| 2022-10-26 | 2 | 0.45 |
| 2022-12-31 | -0.00129 | -0.00134 |
| 2023-02-27 | 0.347 | 0.36 |
| 2023-04-26 | 0.18 | 0.27 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
BioMarin Pharmaceutical stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 26 Feb 2024 | N/A | N/A | N/A | N/A | N/A | |
| 24 Oct 2023 | N/A | N/A | N/A | N/A | N/A | |
| 1 Aug 2023 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 26 Apr 2023 | Beat | $0.18 | $0.27 | 570.62M | N/A | Earnings Call Transcript |
| 27 Feb 2023 | Beat | $0.35 | $0.36 | 537.94M | 537.53M | Earnings Call Transcript |
| 31 Dec 2022 | Missed | -$0 | -$0 | 537.55M | 537.53M | |
| 26 Oct 2022 | Missed | $2 | $0.45 | 481.91M | 505.34M | Earnings Call Transcript |
| 3 Aug 2022 | Beat | $0.1 | $0.15 | 516.55M | 533.79M | Earnings Call Transcript |
| 27 Apr 2022 | Beat | -$1.05 | $0.63 | 797.36M | 519.35M | Earnings Call Transcript |
| 23 Feb 2022 | Beat | $0.03 | $0.03 | 443.03M | 449.81M | Earnings Call Transcript |
| 27 Oct 2021 | Beat | $0.15 | $0.18 | 436.53M | 408.74M | Earnings Call Transcript |
| 28 Jul 2021 | Beat | -$0.04 | $0.07 | 437.06M | 501.69M | Earnings Call Transcript |
| 29 Apr 2021 | Beat | -$0.12 | $0.09 | 447.62M | 486.06M | Earnings Call Transcript |
| 25 Feb 2021 | Beat | -$0.08 | $0.12 | 1.07B | 452.12M | Earnings Call Transcript |
| 5 Nov 2020 | Beat | -$4.99 | $4.01 | 147.43M | 476.78M | |
| 4 Aug 2020 | Missed | $0.52 | $0.32 | 268.42M | 429.48M | Earnings Call Transcript |
| 29 Apr 2020 | Beat | -$2.84 | $0.44 | 57.05M | 502.06M | Earnings Call Transcript |
| 26 Feb 2020 | Beat | -$0.1 | $0.08 | 340.83M | 454.44M | Earnings Call Transcript |
| 23 Oct 2019 | Beat | -$0.93 | $0.3 | 92.21M | 461.09M | Earnings Call Transcript |
| 1 Aug 2019 | Missed | $0.16 | $0.09 | 294.45M | 387.76M | Earnings Call Transcript |
BioMarin Pharmaceutical Earnings report FAQs
When is BioMarin Pharmaceutical's next Earnings date?
The company has not set the next earnings date yet. The latest BioMarin Pharmaceutical's earnings date was on 27 Feb 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.